Poly Medicure Ltd
Pharmaceuticals & Biotechnology | Small Cap
Poly Medicure Ltd demonstrates strong financial health, particularly in solvency, growth, and profitability. The company efficiently manages its debt and showcases robust growth in revenue, operating profit, and earnings per share. High profitability margins and returns on capital employed indicate effective use of resources. However, efficiency ratios related to asset turnover and receivable days suggest areas for improvement. Liquidity is good, providing a buffer for short-term obligations, but financial ratios like adjusted EPS and capital expenditures show moderate performance. Overall, Poly Medicure's strong growth and profitability are slightly tempered by moderate efficiency and financial metrics, presenting a balanced outlook.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio4.60
- Profitability Ratio10.00
- Efficiency Ratio3.67
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio7.18
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Poly Medicure Ltd demonstrates strong financial health, particularly in solvency, growth, and profitability. The company efficiently manages its debt and showcases robust growth in revenue, operating profit, and earnings per share. High profitability margins and returns on capital employed indicate effective use of resources. However, efficiency ratios related to asset turnover and receivable days suggest areas for improvement. Liquidity is good, providing a buffer for short-term obligations, but financial ratios like adjusted EPS and capital expenditures show moderate performance. Overall, Poly Medicure's strong growth and profitability are slightly tempered by moderate efficiency and financial metrics, presenting a balanced outlook.
Overall Valuation Score
P/E RATIO (TTM)
47.16
Industry Median
47.67
Small Cap Median
47.67
P/E RATIO
49.19
P/B RATIO
5.11
Industry Median
5.11
Small Cap Median
5.11
P/S RATIO
7.80
Industry Median
4.61
Small Cap Median
4.61
Others
PEG RATIO
0.00
EV/EBITDA RATIO
26.01
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1563.3 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company exhibits strong growth across all measured metrics, including revenue, operating profit, earnings per share, assets, and net income. This suggests that the company is effectively expanding its operations and increasing its profitability. The company's consistent growth trajectory positions it favorably for future success and market leadership. The company's growth strategies are yielding positive results, enhancing shareholder value.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 17.45 | 20.93 | 23.32 | 21.38 | 12.34 |
| Operating Profit Growth Rate | -0.46 | 24.19 | 35.21 | 26.04 | -2.86 |
| Earnings Per Share (EPS) Growth | 7.83 | 22.32 | 43.98 | 24.15 | -4.88 |
| Asset Growth Rate | 12.5 | 14.52 | 17.88 | 71.71 | 22.78 |
| Net Income Growth Rate | 8.09 | 21.77 | 44.13 | 31.4 | -5.31 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial metrics present a mixed picture. While adjusted earnings per share and dividend per share indicate reasonable profitability and shareholder returns, the book value per share and capital expenditures ratios suggest areas needing attention. The cash earnings per share reflect moderate operational cash generation. The company should focus on improving its capital efficiency and enhancing its book value to strengthen its financial position.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 14.69 | 17.92 | 26.88 | 32.75 | 31.86 |
| Cash Earnings Per Share (Cash EPS) | 20.94 | 24.58 | 33.44 | 41.37 | 42.84 |
| Book Value Per Share | 113.33 | 129.38 | 153.12 | 271.18 | 304.51 |
| Dividend Per Share (DPS) | 2.44 | 2.99 | 2.96 | 3.34 | 3.5 |
| Capital Expenditures (CapEx) | 154 | 239 | 275 | 330 | 305 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company exhibits excellent profitability, with high gross profit margins, return on capital employed, return on equity, return on assets, operating margin, and net margin. This suggests that the company efficiently manages its resources and generates substantial profits. The company's consistent profitability underscores its strong market position. The company's profitability metrics reflect its operational excellence.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.46 | 18.83 | 21.67 | 22.29 | 17.39 |
| Return on Capital Employed (ROCE) | 17 | 18 | 24 | 20 | 14 |
| Return on Equity (ROE) | 13.51 | 14.41 | 17.55 | 12.26 | 10.33 |
| Return on Assets (ROA) | 15.61 | 16.93 | 19.42 | 14.25 | 11.28 |
| Operating Margin | 23.32 | 23.95 | 26.25 | 27.26 | 23.57 |
| Net Margin | 15.94 | 16.05 | 18.76 | 20.31 | 17.12 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company shows mixed efficiency in managing its assets. While inventory and receivables turnover are reasonably managed, the fixed asset and capital turnover ratios suggest that the company is not generating substantial revenue from its fixed assets and overall capital. The days sales in inventory and receivable days indicate moderate efficiency in inventory and credit management. The company could enhance operational performance by optimizing asset utilization.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.89 | 1.76 | 1.59 | 1.54 | 1.1 |
| Inventory Turnover Ratio | 5.18 | 4.8 | 5.01 | 5.12 | 4.3 |
| Receivables Turnover Ratio | 5.08 | 5.05 | 5.45 | 5.38 | 4.26 |
| Days Sales in Inventory Ratio | 70.46 | 76.04 | 72.85 | 71.29 | 84.88 |
| Receivable Days | 71.85 | 72.28 | 66.97 | 67.84 | 85.68 |
| Capital Turnover Ratio | 0.82 | 0.88 | 0.93 | 0.6 | 0.59 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company demonstrates excellent coverage ratios, indicating a strong ability to meet its interest and dividend obligations. This suggests a robust financial position and a reduced risk of financial distress. The company's ample coverage capacity enhances its financial stability and provides a buffer against economic uncertainties. The company's prudent financial management contributes to its long-term sustainability.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 33.5 | 22.55 | 25.57 | 33.36 | 24.72 |
| Equity Dividend Coverage Ratio | 6.25 | 6.25 | 9.09 | 10 | 9.09 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits excellent solvency, indicating a very low level of debt relative to its equity and assets. This suggests a strong financial foundation and a reduced risk of financial distress. The company's reliance on equity to finance its operations enhances its stability and provides a buffer against economic downturns. The company's conservative approach to debt management contributes to its long-term sustainability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.03 | 0.02 | 0 | 0 | 0.02 |
| Debt to Equity Ratio | 0.03 | 0.02 | 0 | 0 | 0.02 |
| Equity Ratio | 0.97 | 0.98 | 1 | 1 | 0.98 |
| Debt To Asset Ratio | 0.03 | 0.01 | 0 | 0 | 0.02 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position indicates a generally healthy ability to meet its short-term obligations. While current and quick ratios suggest adequate liquidity, the cash ratio indicates that the company holds a modest amount of cash relative to its current liabilities. The operating cash flow ratio reflects the company's ability to generate cash from its operations to cover current liabilities. A balanced approach to managing current assets and liabilities is evident, which ensures operational stability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2 | 2.34 | 1.95 | 2.19 | 1.83 |
| Quick Ratio | 1.32 | 1.67 | 1.37 | 1.52 | 1.25 |
| Cash Ratio | 0.06 | 0.58 | 0.38 | 0.36 | 0.12 |
| Operating Cash Flow Ratio | 0.49 | 0.6 | 0.69 | 0.57 | 0.33 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medplus Health Services Ltd | 7.50 | 46.14 | Neutral | 607.00 | 5.20 | 220.00 |
| 2 | Poly Medicure Ltd | 7.37 | 49.19 | Neutral | 442.00 | 33.15 | 321.00 |
Overall, Poly Medicure Ltd's management effectiveness is strong, marked by consistent financial performance and capital efficiency. The company demonstrates robust sales and profit growth, complemented by healthy ROCE and ROE figures. Prudent financial management is evident through controlled debt and consistent dividend payouts. Strategic initiatives are reflected in efficient working capital management and increased promoter holding, showing confidence and alignment with shareholders. The company is well-positioned for sustained performance.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (2025) | 21% | Strong revenue management |
| Return on Capital Employed (ROCE) | 23.28% | Effective use of capital | |
| CONS | Borrowings (Mar 2025) | ₹180 Cr | Increased Long term and short term borrowings |
| Cash Conversion Cycle (Mar 2025) | 207 Days | Indicates potential inefficiency in working capital management |
Financial Performance & Growth
Poly Medicure demonstrates strong financial performance. Compounded sales and profit growth rates are robust. Operating Profit Margin (OPM) has been maintained, suggesting operational efficiency.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Compounded Sales Growth (%) | 12.72% | 13.27% | 16.6% | 20.85% | 23.34% | 21.45% |
| Compounded Profit Growth (%) | 11.84% | -2.3% | 29% | 18.69% | 26.91 | 33.41 |
Sales have grown consistently over the years, from ₹322 Cr in Mar 2014 to ₹1,670 Cr in Mar 2025. The OPM % has also shown improvement, stabilizing around 27% in recent quarters.
Capital Efficiency & Returns
Poly Medicure exhibits strong capital efficiency and returns. Return on Capital Employed (ROCE) and Return on Equity (ROE) are healthy, indicating effective use of capital and shareholder funds.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 29.67% | 24% | 21.33% | 18% | 24% | 20% |
The company's ability to maintain high ROCE and ROE figures indicates that it is generating significant returns from its capital investments.
Financial Health & Prudence
Poly Medicure demonstrates good financial health and prudence. Debt management is under control which is indicated by the Debt/Equity Ratio. The Dividend Payout % shows the company consistently shares profits with shareholders. The Borrowings have increased over the years, from ₹67 Cr in Mar 2014 to ₹180 Cr in Mar 2025.
Strategic & Operational Indicators
Poly Medicure shows positive strategic and operational indicators. Working Capital Management is efficient, as demonstrated by Debtor Days, Inventory Days, and Payables.
The risk assessment for Poly Medicure Ltd indicates a moderate level of risk. While the company demonstrates robust financial performance and efficient capital management, several factors warrant caution. The increasing cash conversion cycle suggests potential inefficiencies in working capital management. Overall, the company's strengths in financial performance and strategic positioning are tempered by the need to monitor and manage specific operational and external risks.
Off-balance sheet exposure quantification
There is no explicit data available to quantify off-balance sheet exposures for Poly Medicure Ltd. Without detailed information, it's difficult to assess the potential risks associated with such exposures.
Contingent liability evaluation
Specific details on contingent liabilities are not provided in the available data for Poly Medicure Ltd. The absence of this information makes it challenging to evaluate the potential financial impact of uncertain future events or obligations.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101568.97Bearish
- SMA 201560.64Bullish
- SMA 501525.48Bullish
- EMA 101564.43Bullish
- EMA 201556.84Bullish
- EMA 501524.23Bullish
- DEMA 101567.95Bearish
- DEMA 201575.44Bearish
- DEMA 501572.71Bearish
- TEMA 101562.96Bullish
- TEMA 201570.56Bearish
- TEMA 501590.59Bearish
- MACD12.85Bearish
- ADX37.47Strong Trend
- IndicatorValueSignal
- RSI56.85Neutral
- CCI10.40Neutral
- ROC 9-0.17Bearish
- ROC 141.78Bullish
- ROC 253.62Bullish
- Stoch K48.68Neutral
- Stoch D49.87Neutral
- IndicatorValueSignal
- BB Upper1588.93Neutral
- BB Middle1560.64Neutral
- BB Lower1532.35Neutral
- ATR16.79Low Volatility
- IndicatorValueSignal
- MFI72.40Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101562.79Bullish
- SMA 201542.97Bullish
- SMA 501473.52Bullish
- EMA 101559.92Bullish
- EMA 201541.17Bullish
- EMA 501498.94Bullish
- DEMA 101574.39Bearish
- DEMA 201578.73Bearish
- DEMA 501536.87Bullish
- TEMA 101570.44Bearish
- TEMA 201580.09Bearish
- TEMA 501576.59Bearish
- MACD26.87Bearish
- ADX36.41Strong Trend
- IndicatorValueSignal
- RSI65.99Neutral
- CCI64.16Neutral
- ROC 91.87Bullish
- ROC 143.88Bullish
- ROC 255.74Bullish
- Stoch K69.45Neutral
- Stoch D74.36Neutral
- IndicatorValueSignal
- BB Upper1591.12Neutral
- BB Middle1542.97Neutral
- BB Lower1494.83Neutral
- ATR20.93Low Volatility
- IndicatorValueSignal
- MFI69.71Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 101541.34Bullish
- SMA 201496.35Bullish
- SMA 501460.34Bullish
- EMA 101540.45Bullish
- EMA 201508.75Bullish
- EMA 501480.72Bullish
- DEMA 101574.98Bearish
- DEMA 201552.15Bullish
- DEMA 501503.10Bullish
- TEMA 101576.26Bearish
- TEMA 201584.36Bearish
- TEMA 50N/AN/A
- MACD34.98Bullish
- ADX32.09Strong Trend
- IndicatorValueSignal
- RSI64.64Neutral
- CCI86.11Neutral
- ROC 92.42Bullish
- ROC 1410.45Bullish
- ROC 2515.88Bullish
- Stoch K88.57Overbought
- Stoch D91.40Overbought
- IndicatorValueSignal
- BB Upper1613.60Neutral
- BB Middle1496.35Neutral
- BB Lower1379.11Neutral
- ATR36.34Low Volatility
- IndicatorValueSignal
- MFI87.02Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101497.22Bullish
- SMA 201452.84Bullish
- SMA 501492.13Bullish
- SMA 1001423.34Bullish
- SMA 2001659.54Bearish
- EMA 101509.29Bullish
- EMA 201486.43Bullish
- EMA 501472.52Bullish
- EMA 1001506.72Bullish
- EMA 2001641.69Bearish
- DEMA 101550.87Bullish
- DEMA 201505.33Bullish
- DEMA 501474.28Bullish
- DEMA 1001388.84Bullish
- DEMA 2001395.72Bullish
- TEMA 101579.47Bearish
- TEMA 201525.08Bullish
- TEMA 501515.91Bullish
- TEMA 1001447.84Bullish
- TEMA 2001290.55Bullish
- MACD19.64Bullish
- ADX18.96Weak Trend
- IndicatorValueSignal
- RSI58.75Neutral
- CCI102.70Overbought
- ROC 1417.20Bullish
- ROC 252.78Bullish
- Stoch K93.61Overbought
- Stoch D91.25Overbought
- IndicatorValueSignal
- BB Upper1630.66Neutral
- BB Middle1452.83Neutral
- BB Lower1275.01Neutral
- ATR63.56Low Volatility
- IndicatorValueSignal
- MFI78.24Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 201401.19Bullish
- SMA 501720.43Bearish
- EMA 201495.51Bullish
- EMA 501678.76Bearish
- DEMA 201396.04Bullish
- DEMA 501440.77Bullish
- TEMA 201458.63Bullish
- TEMA 501275.66Bullish
- MACD-61.60Bullish
- ADX17.39Weak Trend
- IndicatorValueSignal
- RSI47.10Neutral
- CCI-62.75Neutral
- ROC 1413.00Bullish
- ROC 25-15.35Bearish
- Stoch K47.72Neutral
- Stoch D52.15Neutral
- IndicatorValueSignal
- BB Upper1645.76Neutral
- BB Middle1401.19Neutral
- BB Lower1156.62Neutral
- ATR159.19High Volatility
- IndicatorValueSignal
- MFI40.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61433.93Bearish
- SMA 121728.11Bearish
- SMA 242037.83Bearish
- EMA 61476.48Bearish
- EMA 121659.27Bearish
- EMA 241760.87Bearish
- DEMA 61298.04Bullish
- DEMA 121415.03Bearish
- DEMA 241784.40Bearish
- TEMA 61304.75Bullish
- TEMA 121233.76Bullish
- TEMA 241520.83Bearish
- MACD181.97Bearish
- ADX30.71Strong Trend
- IndicatorValueSignal
- RSI48.02Neutral
- CCI-17.40Neutral
- ROC 25-17.86Bearish
- ROC 5042.15Bullish
- Stoch K25.30Neutral
- Stoch D50.92Neutral
- IndicatorValueSignal
- BB Upper2974.35Neutral
- BB Middle2022.64Neutral
- BB Lower1070.93Neutral
- ATR364.06High Volatility
- IndicatorValueSignal
- MFI42.20Neutral